Mexico to begin phase three trials of Sanofi, Walvax COVID-19 vaccines
The Peninsula
MEXICO CITY - Mexico Foreign Minister Marcel Ebrard said on Monday the country will soon begin phase three trials for COVID-19 vaccines by France's Sanofi and China's Walvax.
Mexico's health regulator Cofepris gave approval on Monday for trials of the Sanofi vaccine, which uses a recombinant protein-based technology, Ebrard added. Phase three trials of the vaccine by China's Walvax Biotechnology are also about to begin in Mexico. Walvax, which uses similar technology to the shots by Moderna and Pfizer, will use about 6,000 volunteers for the late-stage trials, the government said previously.More Related News